WIN-Partners Co (TSE:3183) ROCE % : 12.27% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. WIN-Partners Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 12.27%.

WIN-Partners Co ROCE % Historical Data

The historical data trend for WIN-Partners Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co ROCE % Chart

WIN-Partners Co Annual Data

Trend

Mar12

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

16.71

12.61

10.31

11.77

12.57

WIN-Partners Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															20.59	11.28	7.43	10.44	12.27

WIN-Partners Co ROCE % Calculation

WIN-Partners Co's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	2944.927	/	( ( (41564.997 - 18698.56)	+	(43883.327 - 19884.049) )	/ 2 )
	=	2944.927	/	( (22866.437	+	23999.278)	/ 2 )
	=	2944.927	/	23432.8575
	=	12.57 %

WIN-Partners Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	2916.832	/	( ( (42277.029 - 18767.808)	+	(44433.969 - 20407.732) )	/ 2 )
	=	2916.832	/	( ( 23509.221	+	24026.237 )	/ 2 )
	=	2916.832	/	23767.729
	=	12.27 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

WIN-Partners Co (TSE:3183) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

WIN-Partners Co ROCE % Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

WIN-Partners Co (TSE:3183) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031

Website

http://www.win-partners.co.jp

WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines